Liposome Co. reaches milestone

Article

The Liposome Co. and Schering AGhave reached a milestone in their development of TLC I-16, a liposomalnonionic contrast agent for CT scans of the liver. The firms haveagreed on the formulation of the prototype product and will nowproceed from research to

The Liposome Co. and Schering AGhave reached a milestone in their development of TLC I-16, a liposomalnonionic contrast agent for CT scans of the liver. The firms haveagreed on the formulation of the prototype product and will nowproceed from research to a product development program.

The companies will jointly conduct preclinical testing of TLCI-16, with the Liposome Co. responsible for formulation developmentand Schering conducting preclinical studies in animals. Scheringwill provide developmental funding.

TLC I-16 is an imaging agent that is encapsulated within liposomes,using a proprietary process. The product is being developed foruse with CT scans of patients with advanced colon, lung or breastcancer in whom there is suspicion that cancer has metastasizedto the liver.

On regulatory approval of TLC I-16, the Liposome Co. will manufacturethe agent and Schering will market it globally.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.